Literature DB >> 35446556

Facile Preparation of a Thienoisoindigo-Based Nanoscale Covalent Organic Framework with Robust Photothermal Activity for Cancer Therapy.

Rui Xia1,2, Chaonan Li1,2, Xiaodie Yuan1,2, Qihang Wu1,2, Bowen Jiang1,2, Zhigang Xie1,2.   

Abstract

The covalent organic frameworks (COFs) so far are usually built with small aromatic subunits, which makes their absorption spectra mainly located in the high-energy part of the visible region. In this work, we have developed a COF with a low band gap by integrating electron-deficient thienoisoindigo and electron-rich triphenylamine. The intramolecular charge-transfer effect combining the extended length of the π-conjugated backbone of COF endow it with broad absorption even to the second near-infrared region. After optimizing the solvent, a uniform size and colloidal stable COF is obtained. Benefiting from the coplanar structure of the monomer, this COF achieves a considerable photothermal conversion efficiency (PCE) of 48.2%. With these advantages, it displays convincing cancer cell killing effect upon laser irradiation in vitro or in vivo. This work provides a simple and practical method to acquire promising a COF-based phototherapy reagent that is applied in biomedicine field.

Entities:  

Keywords:  covalent organic framework; donor−acceptor structure; photothermal therapy; size controllable; thienoisoindigo

Mesh:

Substances:

Year:  2022        PMID: 35446556     DOI: 10.1021/acsami.2c01701

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

Review 1.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14

2.  A bimodal type of AgPd Plasmonic Blackbody Nanozyme with boosted catalytic efficacy and synergized photothermal therapy for efficacious tumor treatment in the second biological window.

Authors:  Tao Jia; Dan Li; Jiarui Du; Xikui Fang; Valeriy Gerasimov; Hans Ågren; Guanying Chen
Journal:  J Nanobiotechnology       Date:  2022-09-24       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.